SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Watch for Regeneron Pharmaceuticals to Potentially Rebound After Falling 2.05% Yesterday

[January 28, 2013]

Watch for Regeneron Pharmaceuticals to Potentially Rebound After Falling 2.05% Yesterday

Jan 28, 2013 (SmarTrend(R) News Watch via COMTEX) -- Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $170.47 to a high of $176.34. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $170.80 on volume of 701,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean revision.


Over the past year, Regeneron Pharmaceuticals has traded in a range of $42.83 to $188.95 and is now at $170.90, 299% above that low. The 200-day and 50-day moving averages have moved 0.72% higher and 1.60% higher over the past week, respectively.

SmarTrend is tracking the current trend status for Regeneron Pharmaceuticals and will alert subscribers who have REGN in their portfolio or watchlist when shares have changed trend direction.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2013 Technology Marketing Corporation. All rights reserved.